Structure and function of von Willebrand factor: relationship to von Willebrand's disease
- PMID: 1907344
- DOI: 10.1016/s0025-6196(12)61204-x
Structure and function of von Willebrand factor: relationship to von Willebrand's disease
Abstract
This review summarizes the current knowledge of the structure and function of von Willebrand factor and of the pathophysiologic features, diagnosis, classification, and treatment of von Willebrand's disease, the most common congenital bleeding disorder in humans. Specific regions of the von Willebrand factor subunit that are of functional importance have been identified. The structure of these functional domains of von Willebrand factor, as known to date, is described. A classification of von Willebrand's disease, based on the definition of structural and functional abnormalities of the molecule and initial characterization of genetic mutations, is discussed. With more precise characterization of molecular abnormalities, more selective therapeutic intervention for specific subtypes of von Willebrand's disease should eventuate.
Similar articles
-
Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor.Blood. 1982 Dec;60(6):1453-6. Blood. 1982. PMID: 6982737
-
Diagnosis and management of von Willebrand's syndrome.Med Clin North Am. 1994 May;78(3):609-23. doi: 10.1016/s0025-7125(16)30149-3. Med Clin North Am. 1994. PMID: 8170261 Review.
-
Pathogenesis, clinical picture and treatment of von Willebrand's disease.Ann Med. 1995 Dec;27(6):641-51. doi: 10.3109/07853899509019250. Ann Med. 1995. PMID: 8652143 Review.
-
von Willebrand disease: from the bedside to therapy.Thromb Haemost. 1997 Jul;78(1):562-5. Thromb Haemost. 1997. PMID: 9198216 Review.
-
The von Willebrand-syndrome.Blut. 1983 Sep;47(3):123-30. doi: 10.1007/BF00320173. Blut. 1983. PMID: 6411153 No abstract available.
Cited by
-
Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets.Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2869-72. doi: 10.1073/pnas.89.7.2869. Proc Natl Acad Sci U S A. 1992. PMID: 1557393 Free PMC article.
-
Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy.Ann Hematol. 2022 Dec;101(12):2627-2631. doi: 10.1007/s00277-022-04991-9. Epub 2022 Oct 4. Ann Hematol. 2022. PMID: 36194257 Free PMC article.
-
Proteolytic processing of von Willebrand factor subunit: heterogeneity in type-IIA von Willebrand disease.Ann Hematol. 1994 Mar;68(3):111-5. doi: 10.1007/BF01727414. Ann Hematol. 1994. PMID: 8167176
-
A conformation-sensitive monoclonal antibody against the A2 domain of von Willebrand factor reduces its proteolysis by ADAMTS13.PLoS One. 2011;6(7):e22157. doi: 10.1371/journal.pone.0022157. Epub 2011 Jul 11. PLoS One. 2011. PMID: 21779388 Free PMC article.
-
ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women.Med Oncol. 2016 Jul;33(7):67. doi: 10.1007/s12032-016-0784-2. Epub 2016 May 30. Med Oncol. 2016. PMID: 27241035
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources